Many PAD patients fear a heart attack but have never heard of #acutelimbischemia #ALI. The risk is similar to MI and Stroke and the outcomes are poor. Do you talk to your #PAD patients about ALI? #peripheralarterydisease

RT @CUCardiology: The American Journal of Managed Care, Colorado Prevention Center, & the University of Colorado, present: Institute for Va….

RT @VTaqMD: Great to meet new colleagues & see old friends @CUAnschutz for final cardiology #Grand Rounds of 2023-24 #majesticWest #RockyM….

RT @JACCJournals: What is #JACC about? Listen as Editor-in-Chief Dr. Harlan Krumholz details why JACC is focused on impact 💥 and ensuring t….

RT @JACCJournals: 🌟 2023 Impact Factors are in! The #JACCJournals portfolio remains the strongest among the major cardiovascular portfolios….

RT @CardiologyToday: Vascular medicine expert @MarcBonaca gave us his perspective on the new #PAD guidelines ⬇️

RT @me_canonico: Our analysis from VOYAGER-PAD trial published in @CircAHA. New data on Rivaroxaban plus Aspirin in PAD+CAD patients underg….

RT @pcvasc: A weekend well spent discussing plans for preventing and for improving outcomes for patients with CLTI with the top guns in thi….

RT @AHAScience: 1/ Released today, the 2024 Peripheral Artery Disease Guideline was developed by AHA and @ACCIntouch in collaboration with….

RT @ACCmediacenter: We just wrapped our final press conference for #ACC24! ✅ A big thank you to discussants Dr. @MarcBonaca, Dr. @jennifer….

RT @cardiomet_CE: You have found it! Your source for free CE/CME via Twitter! Each program provides 0.5h credit for #physicians, #pharmacis….

Predicting amputation in PAD -.Adding patient comorbidity / diabetes improves risk stratification - should WIFI be DM-WIFI? #ACC2024 #ACC24

Major adverse limb events higher in patients with below knee disease - results from the VOYAGER PAD Angiographic Core Lab #ACC2024 #ACC24

Vascular Year in Review #ACC24 #ACC2024 - exciting new studies including colchicine for AAA!

RT @cpcresearch: Next stop 🛑 in B309 is Kevin Rogers presenting - Risk of Adverse Events in Peripheral Artery Disease Patients with Below-K….

Connie Hess shows new data from VOYAGER PAD on the efficacy and safety of DAPT after endovascular lower extremity revascularization! #ACC2024 #ACC24

RT @AndrewJSauer: @JJheart_doc @MidAmericaHeart @MkosiborodMD @MarcBonaca @JavedButler1 @RyanTedfordMD @robmentz @dranulala @noshreza @mvad….

RT @AndrewJSauer: @MidAmericaHeart is proud to announce we randomized first patient in REDEFINE-HF, an international, randomized, placebo-c….

RT @DKadiandodov: Super excited about the multispecialty faculty (VS, IR, IC, VM) - all passionate about education! Whether you want to set….

RT @me_canonico: Great pleasure to present data from VOYAGER-PAD trial on Fragile patients at #AHA23. @AHAMeetings @PVDCouncil @cpcresearch….

RT @SVM_tweets: A scary map! . #PADCollaborative .Calling all of you to be a FORCE to fight against the amputation epidemic . #AHA23 #PADCo….